crohn's disease and glp-1 Agonists Disease: Risks and Management GLP-1 Medications: Reimagining the Treatment

Short acting agents (such as exenetide) exert their effect mostly by slowing gastric emptying, which reduces post-prandial glucose levels

Deacon CF, Nauck MA, ToftNielsen M, Pridal L, Willms B, Holst JJ

[5] Any insulin dose adjustments should only be made under clinical supervision

high blood pressure, high cholesterol, Pre-Diabetes, cardiovascular disease) It is worth noting that medication should be used in conjunction with lifestyle changes such as healthy eating and physical activity to set you up for a successful journey long term

Gastric emptying is now recognized as a major determinant of postprandial glycemic excursions in both healthy subjects (6) and people with diabetes (7) and accounts for about a third of the variance in the initial rise in glucose postoral challenge (ie, first 15-30 minutes) (6)

2020;105:e2695e2709